Surveys / Trackers / ATUs

The precision medicine market is dynamic, and technological and clinical disruption can cause it to pivot on a dime. Track your markets closely, distinguish signal from noise, and respond accordingly.

Our Experts

Pranay Madan

Andrew Aijian

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

View

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Pharma & Biotech

Cell Therapy Market Trends and Revenue Forecast

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

View

Revenue Projection

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

View

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Pharma & Biotech

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

View

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Financial Services

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

View

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch